NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

330 hedge funds and large institutions have $6.44B invested in Neurocrine Biosciences in 2018 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 110 increasing their positions, 111 reducing their positions, and 89 closing their positions.

Holders
330
Holders Change
-15
Holders Change %
-4.35%
% of All Funds
7.36%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
75
Increased
110
Reduced
111
Closed
89
Calls
$82.5M
Puts
$53.6M
Net Calls
+$28.9M
Net Calls Change
+$52.1M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$252M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$629M
3
CAM
3
Close Asset Management
United Kingdom
$106M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$50.5M
5
CGT
5
Capital Guardian Trust
California
$35.4M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$286M
2
1832 Asset Management
2
1832 Asset Management
Ontario, Canada
$0
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$1.92M
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$41.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
EVM
76
Eaton Vance Management
Massachusetts
$9.24M +$1.59M +22,280 +21%
Federated Hermes
77
Federated Hermes
Pennsylvania
$8.96M -$1.93M -26,988 -18%
VanEck Associates
78
VanEck Associates
New York
$8.62M -$61.8K -865 -0.7%
AQR Capital Management
79
AQR Capital Management
Connecticut
$8.54M +$3.82M +53,487 +81%
EAM
80
Erste Asset Management
Austria
$8.44M +$8.44M +120,900 New
State Board of Administration of Florida Retirement System
81
State Board of Administration of Florida Retirement System
Florida
$8.39M +$61.4K +860 +0.7%
Aberdeen Group
82
Aberdeen Group
United Kingdom
$7.82M -$1.85M -26,127 -19%
BSA
83
Braun Stacey Associates
New York
$7.64M -$3.26M -45,637 -30%
SSA
84
Schonfeld Strategic Advisors
New York
$7.41M +$3.84M +53,789 +108%
Loomis, Sayles & Company
85
Loomis, Sayles & Company
Massachusetts
$7.28M +$80K +1,121 +1%
Massachusetts Financial Services
86
Massachusetts Financial Services
Massachusetts
$7.26M +$803K +11,239 +12%
IBT
87
International Biotechnology Trust
United Kingdom
$7.05M +$5.06M +90,300 +254%
RhumbLine Advisers
88
RhumbLine Advisers
Massachusetts
$6.95M -$308K -4,316 -4%
TD Asset Management
89
TD Asset Management
Ontario, Canada
$6.93M -$2.86M -40,000 -29%
RCAMU
90
Rothschild & Co Asset Management US
Connecticut
$6.54M +$1.78M +24,879 +37%
PPA
91
Parametric Portfolio Associates
Washington
$6.31M -$1.66M -23,288 -21%
Barclays
92
Barclays
United Kingdom
$5.51M +$3.78M +52,969 +219%
Renaissance Technologies
93
Renaissance Technologies
New York
$5.42M +$5.42M +75,841 New
Bank of Nova Scotia
94
Bank of Nova Scotia
Ontario, Canada
$5.07M +$5.07M +71,000 New
Russell Investments Group
95
Russell Investments Group
United Kingdom
$4.98M -$2.63M -36,844 -35%
SCM
96
Sio Capital Management
New York
$4.93M +$4.93M +69,000 New
Citigroup
97
Citigroup
New York
$4.92M +$2.89M +40,511 +143%
WMSA
98
Weiss Multi-Strategy Advisers
New York
$4.71M -$1.36M -19,000 -22%
Nomura Holdings
99
Nomura Holdings
Japan
$4.68M +$675K +9,479 +17%
Bank of Montreal
100
Bank of Montreal
Ontario, Canada
$4.56M +$70.8K +991 +2%
2 3
4
5 6